Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Liver Transpl. 2019 Mar;25(3):369–379. doi: 10.1002/lt.25398

Table 3.

Multivariable Analysis of Predictors of HCC Diagnosis.

Multivariable Analysis of Diagnosis of HCC Within Overall Cohort
Odds Ratio 95% CI P value
Age (year) 1.01 (0.97–1.04) 0.51
Sex (male) 1.56 (0.82–2.99) 0.17
Baseline MELD 0.98 (0.91–1.06) 0.74
Baseline Low Platelets (<100 K/μL) 2.75 (1.37–5.53) 0.004
Baseline Alpha Fetoprotein 1.00 (0.99–1.02) 0.37
Baseline Albumin (<3.4 g/dL) 2.77 (1.43–5.35) 0.002
Multivariable Analysis of Diagnosis of HCC Among Patients with Abnormal Imaging
Odds Ratio 95% CI P value
Age (year) 1.00 (0.96–1.04) 0.83
Sex 1.02 (0.43–2.41) 0.06
Baseline MELD 0.92 (0.81–1.05) 0.23
Baseline Thrombocytopenia (<100 K/μL) 3.67 (1.46–9.23) 0.006
Baseline Alpha Fetoprotein 1.02 (0.99–1.05) 0.15
Baseline Hypoalbuminemia (<3.4 g/dL) 4.07 (1.56–10.63) 0.004
Maximum Nodule Size ≥ 2.0 cm 8.63 (3.55–20.92) <0.001

MELD – model of endstage liver disease